
(loo sin ak’ tant)
Surfaxin
UNKNOWN
Drug class
Lung surfactant
Therapeutic Actions
Nonpyrogenic pulmonary surfactant containing lipids and peptides that reduce surface tension and all expansion of the alveoli; replaces the surfactant missing from the lungs of preterm infants
Indications
-
Prevention of RDS in preterm infants at high risk for RDS
Contraindications and Cautions
-
None known.
Available Forms
Suspension—8.5 mL/vial

Full access? Get Clinical Tree

